Results
23
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
23 companies
Divi's Laboratories
Market Cap: ₹1.7t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹6,580.00
7D
10.7%
1Y
67.5%
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,302.80
7D
2.0%
1Y
22.1%
WuXi XDC Cayman
Market Cap: HK$46.1b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$38.35
7D
6.2%
1Y
129.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥38.0b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥84.55
7D
0.6%
1Y
40.6%
Ipca Laboratories
Market Cap: ₹364.5b
A pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia.
IPCALAB
₹1,436.80
7D
4.8%
1Y
9.7%
Gan & Lee Pharmaceuticals
Market Cap: CN¥30.5b
A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.
603087
CN¥50.90
7D
0.2%
1Y
5.2%
Xiamen Amoytop Biotech
Market Cap: CN¥29.6b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥72.70
7D
-2.4%
1Y
26.2%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹259.1b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,663.95
7D
6.5%
1Y
-9.6%
Sai Life Sciences
Market Cap: ₹156.2b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹749.05
7D
4.9%
1Y
n/a
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥12.3b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥54.83
7D
3.3%
1Y
-3.6%
Blue Jet Healthcare
Market Cap: ₹142.0b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹818.75
7D
11.4%
1Y
122.6%
Xiamen Kingdomway Group
Market Cap: CN¥11.4b
Engages in the manufacturing and sale of the nutrition and health products in China and internationally.
002626
CN¥18.76
7D
11.5%
1Y
19.1%
Granules India
Market Cap: ₹124.0b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.
532482
₹511.50
7D
11.3%
1Y
25.8%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.4b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.51
7D
-0.4%
1Y
30.0%
Aether Industries
Market Cap: ₹98.3b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹741.65
7D
-8.0%
1Y
-10.8%
Acutaas Chemicals
Market Cap: ₹97.3b
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
AMIORG
₹1,188.90
7D
0.4%
1Y
91.1%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥7.8b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥15.76
7D
-1.5%
1Y
-39.4%
Consun Pharmaceutical Group
Market Cap: HK$8.1b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.67
7D
2.7%
1Y
39.9%
Akums Drugs and Pharmaceuticals
Market Cap: ₹86.9b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹552.35
7D
8.9%
1Y
n/a
Innova Captab
Market Cap: ₹52.9b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹923.60
7D
-0.9%
1Y
78.2%
Beijing Kawin Technology Share-Holding
Market Cap: CN¥4.4b
A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.
688687
CN¥26.36
7D
2.4%
1Y
-11.5%
ChengDu ShengNuo BiotecLtd
Market Cap: CN¥3.9b
Engages in the research and development, production, sale, and export of peptide drugs.
688117
CN¥34.96
7D
8.0%
1Y
26.7%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.37
7D
2.6%
1Y
72.0%